LOS ANGELES — In this Healio Video Perspective from the ASCRS meeting, Anthony Wallace, of Bausch + Lomb, provides further details on the return to market of enVista IOLs.As Healio previously reported, Bausch + Lomb voluntarily recalled the enVista pla…
Author: Healio ophthalmology
Shock wave therapy could have utility in presbyopia, cataracts
LOS ANGELES — The future of refractive surgery could see ophthalmology welcome sound waves as a therapeutic tool, according to a speaker at the American Society of Cataract and Refractive Surgery meeting.In the Roger F. Steinert, MD, Refractive Lecture…
Patients with irregular astigmatism candidates for topography-guided excimer ablation
LOS ANGELES — Topography-guided laser vision correction offers several benefits: It is not dependent on pupil size, can be measured reproducibly and is not influenced by vitreous opacities, according to a speaker.During Refractive Day at the American S…
VIDEO: Nordic, Harrow launch generic Maxitrol
LOS ANGELES — Nordic Pharma and Harrow partnered to launch an authorized generic of Maxitrol, Nordic President Philip Gioia said in this Healio Video Perspective from SightLine.Gioia said the neomycin and polymyxin B sulfates and dexamethasone ophthalm…
‘Virtual eye’ simulation software may improve refractive surgery outcomes
LOS ANGELES — Simulation software designed to build a virtual eye may help predict the outcomes of laser vision correction before surgery, resulting in a more individualized treatment approach, according to a speaker here.At Refractive Day at the Ameri…
Survey: Surgeons more pessimistic than industry about financial future of ophthalmology
LOS ANGELES — Results of a survey conducted among ophthalmic industry, administrators and surgeons revealed that industry representatives are most optimistic about the financial future of commercial ophthalmology.American Society of Cataract and Refrac…
Bill to end mandatory prophylaxis for newborn eye infections sent to W.Va. governor
A bill recently passed by the West Virginia legislature would undo the state’s mandate for newborns to receive prophylaxis against ophthalmia neonatorum, a potentially blindness-causing eye infection.As of April 23, House Bill 3444 was headed to Gov. P…
Tired of pleasing ‘corporate masters,’ physician union membership rises
Union membership among health care professionals in the United States, including physicians, is on the rise, which could have seismic implications in work patterns and patient care in an increasingly corporatized medical system.“The trend toward physic…
Bausch + Lomb to return enVista IOLs to market after voluntary recall
Editor’s note: This is a developing news story. Please check back soon for updates.Bausch + Lomb will return its enVista IOLs to market after identifying the event that led to a voluntary recall, according to a press release.The company recalled the le…
VIDEO: Will sustained drug delivery be the new treatment paradigm for retinal disease?
SEVILLE, Spain — In this Healio Video Perspective from the Congress on Controversies in Ophthalmology, Lloyd Clark, MD, discusses sustained drug delivery implants as a treatment option for retinal diseases.During a session, Clark and Dan Martin, MD, de…
Can general ophthalmologists take on some of the workload of glaucoma specialists?
SEVILLE, Spain — While glaucoma prevalence is growing, glaucoma specialists are in short supply, and accessibility to specialized centers is limited. Can this gap be filled by general ophthalmologists?This issue was debated at the Congress on Controver…
FDA clears Luminopia for amblyopia in children aged 8 to 12 years old
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA cleared Luminopia, a virtual reality-based therapeutic for amblyopia, for use in children aged 8 to 12 years old, adding to its existing approval in children age…
VIDEO: Specialist highlights benefits of new-generation anti-VEGFs
SEVILLE, Spain — In this Healio Video Perspective from the Congress on Controversies in Ophthalmology, Patricia Udaondo, MD, PhD, highlights the meeting’s debate sessions on new anti-VEGF therapies.She addressed treatment durability, maintenance of fun…
Incidence of hernias, scoliosis, flat feet suggests link between myopia, tissue laxity
Adolescents with myopia had hernias, scoliosis and flat feet significantly more often than those without, suggesting a possible link between nearsightedness and overall connective tissue hyperlaxity, according to a study.“Previous studies have establis…
Decellularized AMBM graft, pressure patch combination improves corneal epithelial defects
A combination of eyelid pressure patching and decellularized, dehydrated pure amniotic membrane basement membrane healed persistent corneal epithelial defects, according to a study published in Ophthalmology and Therapy.“Patients with persistent cornea…
VIDEO: COPHy weighs preservative-free glaucoma drops, minimally invasive bleb surgeries
SEVILLE, Spain — In this Healio Video Perspective, M. Francesca Cordeiro, MD, PhD, summarizes three more hot topics in glaucoma discussed at the Congress on Controversies in Ophthalmology.The questions included: Should comprehensive ophthalmologists or…
FDA takes steps to reduce animal testing requirements for monoclonal antibodies
Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced” in favor of other approaches, including artificial intelligence, according to a recent announcement from the FDA.“For too lon…
VIDEO: Faricimab for retinal vein occlusion helpful in real-world practice
In this expert perspective, Manjot K. Gill, MD, discusses faricimab for the management of retinal vein occlusion.Gill, vice chair of clinical performance and ophthalmology professor at Northwestern Feinberg School of Medicine, said that patients with r…
VIDEO: Aflibercept 8 mg may offer enhanced efficacy, durability in retinal vein occlusion
In this expert perspective, Manjot K. Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion.Gill, vice chair of clinical performance and ophthalmology professor at Northwestern Feinberg S…
FDA does not approve additional extended dosing intervals for Eylea HD
Editor’s note: This is a developing news story. Please check back soon for updates.The FDA issued a complete response letter for a supplemental biologics license application, in which it did not approve extending the dosing intervals for Eylea HD, acco…